Tag: M.W:100-200

2213-63-0, Name is 2,3-Dichloroquinoxaline, belongs to quinoxaline compound, is a common compound. 2213-63-0In an article, authors is Abulkhair, Hamada S., once mentioned the new application about 2213-63-0.

Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists

Abstract: Many shreds of evidence have recently correlated A2B receptor antagonism with anticancer activity. Hence, the search for an efficient A2B antagonist may help in the development of a new chemotherapeutic agent. In this article, 23 new derivatives of [1,2,4]triazolo[4,3-a]quinoxaline were designed and synthesized and its structures were confirmed by different spectral data and elemental analyses. The results of cytotoxic evaluation of these compounds showed six promising active derivatives with IC50 values ranging from 1.9 to 6.4 muM on MDA-MB 231 cell line. Additionally, molecular docking for all synthesized compounds was performed to predict their binding affinity toward the homology model of A2B receptor as a proposed mode of their cytotoxic activity. Results of molecular docking were strongly correlated with those of the cytotoxic study. Finally, structure activity relationship analyses of the new compounds were explored. Graphic abstract: [Figure not available: see fulltext.].

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 2213-63-0

Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1235 | ChemSpider

One of the major reasons for studying chemical kinetics is to use measurements of the macroscopic properties of a system, 59564-59-9, such as the rate of change in the concentration of reactants or products with time.In a article, authors is Mickelson, John W., mentioned the application of 59564-59-9, Name is 3,4-Dihydroquinoxalin-2(1H)-one, molecular formula is C8H8N2O

High-affinity alpha-aminobutyric acid A/benzodiazepine ligands: Synthesis and structure – Activity relationship studies of a new series of tetracyclic imidazoquinoxalines

A series of tetracyclic imidazoquinoxaline analogs was developed which constrain the carbonyl group of the partial agonist 3-(5-cyclopropyl-1,2,4- oxadiazol-3-yl)-5-[(dimethylamino)carbonyl]4,5-dihydroimidazo[1,5- a]quinoxaline (2, U-91571) away from the benzene ring. These analogs orient the carbonyl group in the opposite direction of the previously reported full agonist 1-(5-cyclopropyl- 1,2,4-oxadiazol-3-yl)- 12,12a-dihydroimidazo[1,5- a]pyrrolo[2,1-c]quinoxalin- 10(11H)one (3, U-89267). A number of approaches were utilized to form the ‘bottom’ ring of this tetracyclic ring system including intramolecular cyclizations promoted by Lewis acids or base, as well as metal-carbenoid conditions. The size and substitution pattern of the additional ring was widely varied. Analogs within this series had high affinity for the benzodiazepine receptor on the alpha-aminobutyric acid A chloride ion channel complex. From TBPS shift and Cl- current assays, the in vitro efficacy of compounds within this class ranged from antagonists to partial agonists with only 18a identified as a full agonist. Additionally, several analogs were quite potent at antagonizing metrazole-induced seizures indicating possible anticonvulsant or anxiolytic activity. Unlike 3, analogs in this series did not have high affinity for the diazepam insensitive alpha6beta2delta2 subtype. These results suggest that either constraining the carbonyl group away from the benzene ring or the greater planarity that results from the additional cyclic structure provides analogs with partial agonist properties and prevents effective interaction with the alpha6beta2delta2 subtype.

Sometimes chemists are able to propose two or more mechanisms that are consistent with the available data. 59564-59-9, If a proposed mechanism predicts the wrong experimental rate law, however, the mechanism must be incorrect.Welcome to check out more blogs about 59564-59-9, in my other articles.

Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N173 | ChemSpider

Chemistry is traditionally divided into organic and inorganic chemistry. 15804-19-0, The former is the study of compounds containing at least one carbon-hydrogen bonds.In a patent£¬Which mentioned a new discovery about 15804-19-0

NOVEL TRICYCLIC COMPOUNDS AND PROCESS FOR PREPARATION THEREOF

The present invention relates to novel tricyclic compounds of formula (I) and (II) More particularly, the present invention relates to novel tricyclic compounds of formula (I) and (II) and process of preparation of these compounds from 4, 5-dimethyl-o-phenylinediamine. Further, the present invention relates to a process for preparation of tricyclic compound hunanamycin A.

One of the oldest and most widely used commercial enzyme inhibitors is aspirin, 15804-19-0, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 15804-19-0

Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N271 | ChemSpider

Let¡¯s face it, organic chemistry can seem difficult to learn. Especially from a beginner¡¯s point of view. Like 2213-63-0, Name is 2,3-Dichloroquinoxaline. In a document type is Article, introducing its new discovery., 2213-63-0

Construction of a bidentate arsenic ligand library starting from a cyclooligoarsine

Bidentate ligands are, needless to say, pivotal in organo-metallic chemistry. In contrast to phosphorus ligands, practical synthetic protocols for the arsenic analogues remain to be developed, resulting in a lack of bidentate arsenic ligands. Herein the methods that we have recently developed were applied for bidentate arsenic ligands whose frameworks are well known in phosphorus ligand systems such as dppe, dppp, dppf, xantphos, etc. The palladium dichloride complexes of the obtained ligands were synthesized and used for the Suzuki-Miyaura coupling reaction.

If you¡¯re interested in learning more about 38642-74-9, below is a message from the blog Manager. 2213-63-0

Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1371 | ChemSpider

1448-87-9, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1448-87-9, name is 2-Chloroquinoxaline, introducing its new discovery.

TRIAZOLE COMPOUNDS AS LIPOXYGENASE INHIBITORS

There is provided compounds of formula (I) wherein W is an optionally substituted aryl or heteroaryl group, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a lipoxygenase (e.g. 15- lipoxygenase) is desired and/or required, and particularly in the treatment of inflammation.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.1448-87-9, you can also check out more blogs about1448-87-9

Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N455 | ChemSpider

2213-63-0, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.2213-63-0, Name is 2,3-Dichloroquinoxaline, molecular formula is C8H4Cl2N2. In a Article, authors is Soncini, Paolo£¬once mentioned of 2213-63-0

Cavitands as Versatile Molecular Receptors

X-ray crystal structure of 3*2PhF and 1H NMR complexation studies in solution reveal the strong tendency of cavitand 3 to selectively bind aromatic guests in organic solution.The association constants (Ka) for eight 1:1 caviplexes formed in acetone-d6 were determined.The solvation effect is largely responsible for the relatively low Ka values observed.The orientation assumed by the guests inside the cavity is determined by dipole-dipole interactions between the host and the guest; additional CH3-? interactions are present in the case of 3*3(CH3)2CO.The modification of the structure of 3 by introducing a suitable and furtherly modifiable substituent allowed the synthesis of optically pure chiral cavitand 5. 1H NMR complexation studies of 5 in acetone-d6 reveal that the CH2OH group perching on top of the cavity rim affects the selectivity but not the orientation of the included aromatic guests for the 1:1 caviplexes formed.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.2213-63-0. In my other articles, you can also check out more blogs about 2213-63-0

Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1555 | ChemSpider

15804-19-0, In heterogeneous catalysis, the catalyst is in a different phase from the reactants. At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 15804-19-0, name is Quinoxaline-2,3(1H,4H)-dione. In an article£¬Which mentioned a new discovery about 15804-19-0

Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring receptors

Whole-cell recordings were used to study the antagonist pharmacology of two subtypes of non-N-methyl-D-aspartate glutamate receptors: the kainate- preferring subtype expressed by rat dorsal root ganglion (DRG) neurons and the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-preferring subtype expressed by neurons from rat cerebral cortex. A series of quinoxaline derivatives were tested for the ability to distinguish between AMPA and kainate receptors, as determined by differential potency. Of the nine compounds studied, 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)quinoxaline (NBQX) showed the highest selectivity for AMPA-preferring receptors, whereas 5-chloro-7-trifluoromethyl-2,3-quinoxalinedione (ACEA-1011) showed the highest selectivity for the kainate-preferring subtype. NBQX blocked non-N- methyl-D-aspartate currents in cortical cells with a K(b) of 0.3 muM, but in DRG neurons the K(b) for NBQX was 3-fold higher (0.9 muM). ACEA-1011 also blocked the currents in DRG cells with a K(b) of ~1 muM, but in cortical neurons the K(b) for this drug was 10-12 muM. Several additional compounds were tested for selective potency, including 5-nitro-6,7,8,9- tetrahydrobenzo[G]indole-2,3-dione-3-oxime, gamma-D-glutamylaminomethylsulphonic acid, and derivatives of kynurenic acid and 1-benzazepine. 5-Nitro-6,7,8,9- tetrahydrobenzo[G]indole-2,3-dione-3-oxime displayed the highest selectivity in this group, blocking kainate receptors with a K(b) of 6 muM while inhibiting AMPA receptors with a K(b) of >100 muM. The remaining antagonists showed <3-fold selectivity between AMPA and kainate receptor subtypes. Our results suggest that most competitive antagonists block native AMPA and kainate receptors with approximately similar potencies, which is in marked contrast to the substantial differences in potency that have been observed with receptor agonists. The proportionality constant is the rate constant for the particular unimolecular reaction. the reaction rate is directly proportional to the concentration of the reactant. I hope my blog about 15804-19-0 is helpful to your research. 15804-19-0

Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N413 | ChemSpider

2213-63-0, Catalysts function by providing an alternate reaction mechanism that has a lower activation energy than would be found in the absence of the catalyst. In a patent, 2213-63-0, molecular formula is C8H4Cl2N2, introducing its new discovery.

Novel [1,2,4]Triazolo[4,3-a]Quinoxaline Derivative, Method For Preparing Same, And Pharmaceutical Composition For Preventing Or Treating BET Protein-Related Diseases, Containing Same As Active Ingredient

Provided are a novel [1,2,4]triazolo[4,3-a]quinoxaline derivative, a method for preparing the same, and a pharmaceutical composition for preventing or treating bromodomain extra-terminal (BET) protein-related diseases including cancer and autoimmune diseases, containing the same as an active ingredient.

Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.2213-63-0, you can also check out more blogs about2213-63-0

Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1151 | ChemSpider

2213-63-0, The reaction rate of a catalyzed reaction is faster than the reaction rate of the uncatalyzed reaction at the same temperature.2213-63-0, Name is 2,3-Dichloroquinoxaline, molecular formula is C8H4Cl2N2. In a Article, authors is Soliman£¬once mentioned of 2213-63-0

Synthesis and antimicrobial activity of some novel quinoxalines

2-Hydrazino-3-chloroquinoxaline 2 was prepared and reacted with active methylene compounds, potassium thiocyanate, carbon disulfide, phenylisothiocyanate, acetic acid, ethyl chloroformate, triethyl orthoformate, and Lawessen’s reagent (LR) to give a new class of fused quinoxalines 4-16, respectively. Also, 2,3-dihydrazinoquinoxaline 3 was prepared and reacted with carbon disulfide, phenyl isothiocyanate, and triethyl orthoformate to give the corresponding di[1,2,4] triazolo-[4,3-a:3?,4?-c]-quinoxalines 17-19, respectively. Reaction of 3 with LR gave the corresponding di[1,2,4,3] triazophospholo[4,5-a:5?,4?-c]quinoxaline-1,6-dithione (20). It was found that all synthesized compounds exhibit antimicrobial activity and that compound 20 had a broad spectrum of activity. Copyright Taylor & Francis Group, LLC.

Balanced chemical reaction does not necessarily reveal either the individual elementary reactions by which a reaction occurs or its rate law.2213-63-0. In my other articles, you can also check out more blogs about 2213-63-0

Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N1551 | ChemSpider

Because a catalyst decreases the height of the energy barrier, 25594-62-1, its presence increases the reaction rates of both the forward and the reverse reactions by the same amount.25594-62-1, Name is 2-Acetylquinoxaline, molecular formula is C10H8N2O. In a article£¬once mentioned of 25594-62-1

Asymmetric Michael Addition of 2-Acetyl Azaarenes to beta-CF3-beta-(3-indolyl)nitroalkenes Catalyzed by a Cobalt(II)/(imidazoline-oxazoline) Complex

The first enantioselective Michael addition of 2-acetyl azaarenes to beta-CF3-beta-(3-indolyl)nitroalkenes has been successfully achieved in the presence of a Co(II)/(imidazoline-oxazoline) complex as the catalyst. The reaction affords a series of CF3- A nd 3-indole-containing adducts featuring a trifluoromethylated all-carbon quaternary stereocenter in good to excellent yields (up to 99%) and enantioselectivities (up to 96% ee). Furthermore, the functional groups in the adducts including Ca?O, NO2, and the azaarene provide a large variety of useful transformations, leading to the formation of valuable intermediates such as optically active secondary alcohol, pyrroline, ester, and pyrrolidinone which all contain a 3-substituted indole and a trifluoromethylated all-carbon quaternary stereocenter.

A reaction mechanism is the microscopic path by which reactants are transformed into products. Each step is an elementary reaction. 25594-62-1, In my other articles, you can also check out more blogs about 25594-62-1

Reference£º
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N761 | ChemSpider